Finance

Beta
Lists
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$1.72
-1.15%
(-0.020) 1D
$1.72
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALDX...
Open
$1.76
High
$1.83
Low
$1.68
Mkt. cap
103.75M
Avg. vol.
993.31K
Volume
961.30K
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
Open
$1.76
High
$1.83
Low
$1.68
Mkt. cap
103.75M
Avg. vol.
993.31K
Volume
961.30K
52-wk high
$6.18
52-wk low
$1.07
EPS
-$0.46
Beta
1.19
Shares outstanding
60.32M
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to ALDX in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ALDX in the last 3 months.
Highest
Current $1.72
$9.00 (+423.26%)
Average
$5.50 (+219.77%)
Lowest
$2.00 (+16.28%)
News stories
From sources across the web
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees7
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.51M
5.43M
4.30M
2.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.66M
2.57M
2.36M
1.14M
Operating expense
10.17M
8.00M
6.67M
3.55M
Total operating expenses
10.17M
8.00M
6.67M
3.55M
Operating income
-10.17M
-8.00M
-6.67M
-3.55M
Other non operating income
-
-
-
-
EBT including unusual items
-9.77M
-7.69M
-6.46M
-3.45M
EBT excluding unusual items
-9.77M
-7.69M
-6.46M
-3.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.77M
-7.69M
-6.46M
-3.45M
Net profit margin
-
-
-
-
Earnings per share
-0.16
-0.13
-0.10
-0.06
Interest and investment income
872.04K
788.69K
681.64K
562.98K
Interest expense
-470.62K
-475.90K
-475.26K
-468.68K
Net interest expenses
401.42K
312.79K
206.38K
94.30K
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.11M
-7.94M
-6.60M
-3.48M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more